Cost-benefit analysis of universal tandem mass spectrometry for newborn screening.

@article{Schoen2002CostbenefitAO,
  title={Cost-benefit analysis of universal tandem mass spectrometry for newborn screening.},
  author={Edgar J. Schoen and John C. Baker and Christopher J. Colby and Trinh T To},
  journal={Pediatrics},
  year={2002},
  volume={110 4},
  pages={781-6}
}
OBJECTIVE To estimate potential costs and benefits of routinely using tandem mass spectrometry (MS/MS) to screen newborns for inborn errors of metabolism. METHOD Analysis of costs and benefits resulting from use of MS/MS in screening of 32 000 newborn infants using data from the Kaiser Permanente Medical Care Program of Northern California plus other published data. SETTING A large health maintenance organization. RESULTS In the base scenario, the cost per quality-adjusted life year saved… CONTINUE READING